WASHINGTON, May 11 /PRNewswire/ -- What: The development of continuous glucose monitoring and an artificial pancreas could be the next major scientific advance in diabetes treatment and, eventually, a cure. Join representatives from the JDRF, leading academic researchers and people with type 1 -- or juvenile -- diabetes, to learn about this rapidly expanding field of medical technology. Hear about regulatory and insurance reimbursement milestones, patient reactions to artificial pancreas technology, and the impact a closed-loop artificial pancreas is expected to have on the lives of people with diabetes and the healthcare industry. When: Friday, May 12, 2006, 11:45 AM - 1:00 PM. Lunch to be served. Where: The JW Marriott Hotel, Independence Room, 1331 Pennsylvania Avenue, NW, Washington, DC Who: Mary Tyler Moore, International Chairman, JDRF William V. Tamborlane MD, Professor & Chief, Department of Pediatrics, Yale University School of Medicine Stuart Weinzimer, MD, Assistant Professor of Pediatrics, Yale University School of Medicine Aaron Kowalski, PhD, Director of Strategic Research Projects, JDRF Cynthia Rice, Director of New Technology Access, JDRF
Juvenile Diabetes Research Foundation
CONTACT: Meryl Rader for JDRF, +1-908-389-9804, or meryl@erbachcom.com
